SyncoZymes

ozi

Ozi ọma: Aghọtala Shangke Bio dị ka ọrụ mgbanwe mmega nke teknụzụ dị elu

Na Jenụwarị 5, 2021, Shangke Biopharmaceutical (Shanghai) Co., Ltd. enwetara "(S) -1-tert-butoxycarbonyl-3-hydroxypiperidine" Shanghai High-tech Achievement Transformation Project.

Dịka ụlọ ọrụ teknụzụ dị elu nke mba, Suntech Biotech na-ewere teknụzụ biotechnology mgbe niile iji duga mmepe nke ụlọ ọrụ kemịkalụ na ọgwụ, ma na-ewetara ụmụ mmadụ akwụkwọ ndụ akwụkwọ ndụ na ahụike dịka ebumnuche ya.Iji gbasaa azụmahịa n'ọtụtụ ụzọ, na-arụkọ ọrụ ọnụ na ụlọ akwụkwọ a ma ama na ụlọ ọrụ na ụlọ na mba ọzọ, na-emepewanye ikike mmepe nke ya mgbe niile, na-ebuli nhazi nke ụlọ ọrụ ahụ, ma na-adịwanye mma ma na-esiwanye ike.

elu-tech rụzuru

Aha oru: (S) -1-tert-Butoxycarbonyl-3-hydroxypiperidine
Item nọmba: 202010694
Ọkwa ihe: B
Ma enwere mmezu na mpaghara teknụzụ dị elu nwere ikike ọgụgụ isi nwere onwe: Ee

Ngwa: (S) -1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) bụ etiti chiral dị mkpa maka njikọ nke ibrutinib API.Ibrutinib bụ ọgwụ ọhụrụ anticancer na-ezubere iche maka ọrịa ọjọọ B-cell nke akwadoro n'okpuru nkwado ngwa ngwa nke US Food and Drug Administration (FDA) na Nọvemba 13, 2013 maka ọgwụgwọ nke lymphoma.

Nkọwa nke mgbanwe mmezu nke teknụzụ dị elu
The mgbanwe nke elu-tech rụzuru na-ezo aka na usoro nke ụlọ ọrụ na-eme elu-tech mmepụta na ọrụ.Steeti na-akwado ụlọ ọrụ iji mejuputa mgbanwe nke sayensị na teknụzụ site na nyocha na mmepe onwe, inye ikike, iwere òkè na ọnụ ahịa, yana ịkwado ụlọ ọrụ, mahadum na ụlọ ọrụ nyocha.N'ihi na elu-tech rụzuru mgbanwe oru enyocha na kọrọ site Enterprise, dị ka ẹkụre nke keukwu aku na uba egosi na àgwà nke oru ngo si ikike ikike ọgụgụ isi, ogo nke ọhụrụ, wdg, ya R&D ego metụtara oru ngo. ikike ikike ọgụgụ isi metụtara, asambodo patent mepụtara, ma ọ bụ ndị na-abanye na ọkwa nyocha dị mkpa.Asambodo nsọpụrụ enyere ụlọ ọrụ ahụ mgbe nyochachara nke ọma na nyocha ahịa nke ọma, dị ka ihe akaebe nke ngwa patent mepụtara, asambodo patent ihe eji eme ihe, asambodo ndebanye nwebiisinka sọftụwia, asambodo ndebanye aha okirikiri okirikiri agbakwunyere, wdg.

Nkọwapụta Ụlọ ọrụ
E hiwere Shangke Biomedical (Shanghai) Co., Ltd na 2008 ma dị na International Medical Park, mpaghara ndịda nke Zhangjiang Hi-Tech Park, Pudong, Shanghai.Ọ bụ a kpamkpam-ekesịpde enyemaka nke Zhejiang Shangke Biomedical Co., Ltd. Shangke Bio na-agba mbọ na nyocha na mmepe nke kasị egbu ọnụ akwụkwọ ndụ akwụkwọ ndụ ọgwụ ubi, na-eduga mmepe nke kemịkalụ ọgwụ ụlọ ọrụ na green biotechnology, na-enye ọhụrụ. ngwaahịa na ọrụ dị elu maka ụlọ ọrụ ọgwụ.Ọ bụ ụlọ ọrụ teknụzụ dị elu na Shanghai yana ụlọ ọrụ teknụzụ dị elu nke Shanghai “pụrụ iche, nụchara anụcha, pụrụ iche na nke ọhụrụ” ụlọ ọrụ.

Isi azụmahịa nke Suntech gụnyere: mmepe na ntinye nke enzymes ndu, mmepe na mmepụta nke intermediates ọgwụ, API na kemịkalụ arụ ọrụ.Ngwaahịa bụ isi nke ụlọ ọrụ ahụ bụ ngwaahịa coenzyme, gụnyere NMN, NAD, NADP, NADH, NADPH, enzymes biological, akụrụngwa ọgwụ na etiti.Ndị ahịa na ndị mmekọ ụlọ ọrụ ahụ nọ n'ụwa niile, yana ya na ọtụtụ ụlọ ọrụ na-emepụta ọgwụ na North America, Europe, India na China na-enwe mmekọrịta chiri anya.


Oge nzipu: Jan-15-2021